BSV-Portfolio-IVEnsure

IV Ensure

Life Sciences

IV Ensure has developed a solution to the 50%+ hospital readmission rates resulting from non-adherence to home infusion treatment plans caused by the shortages of qualified case managers, nurses and funding for home visits.

Why we invested:

BSV-Portfolio-IVEnsure-MarketNeed-V2

Market Need

Over 50% of hospital readmission rates are due to non-adherence to home infusion treatment plans.

BSV-Portfolio-IVEnsure-SuperiorTech

Superior Technology

95% of all infusions outside hospital settings are done with non-electronic elastomeric ball infusions. IV Ensure has the only patented remote monitoring device designed for these systems.

BSV-Portfolio-IVEnsure-Team-V2

Founder & Team

Founder/CEO Mitchell Berenson previously co-founded Community Infusion Systems in 2008. Debbie Meyer, a partner at embedded systems design and manufacturing company SoftwareCannery, developed the initial proof of concept for the IV Ensure device.

Question? Just schedule a call with the BSV team.